,

Pharmacokinetics in Drug Development

Advances and Applications, Volume 3

Specificaties
Gebonden, 319 blz. | Engels
Springer US | 2011e druk, 2011
ISBN13: 9781441979360
Rubricering
Springer US 2011e druk, 2011 9781441979360
Verwachte levertijd ongeveer 8 werkdagen

Samenvatting

The topics chosen for this volume were selected because they are some of the current development or technological issues facing drug development project teams.  They regard the practical considerations for assessment of selected special development populations.  For example, they include characterization of drug disposition in pregnant subjects, for measuring arrhythmic potential, for analysis tumor growth modeling, and for disease progression modeling.  Practical considerations for metabolite safety testing, transporter assessments, Phase 0 testing, and development and execution of drug interaction programs reflect current regulatory topics meant to address enhancement of both safety assessment and early decision-making during new candidate selection.  Important technologies like whole body autoradiography, digital imaging and dried blood spot sample collection methods are introduced, as both have begun to take a more visible role in pharmacokinetic departments throughout the industry. 

Specificaties

ISBN13:9781441979360
Taal:Engels
Bindwijze:gebonden
Aantal pagina's:319
Uitgever:Springer US
Druk:2011

Inhoudsopgave

<p>Preface</p><p>1.    Modeling Tumor Growth in Oncology</p><p>Peter L. Bonate</p><p>2.    Drug-Drug Interactions: Designing Development Programs and Appropriate Product Labeling</p><p>J. Matthew Hutzler, Jack Cook, and Joseph C. Fleishaker</p><p>3.    Modeling the Progression of Disease</p><p>Diane R. Mould</p><p>4.    The Use of Dried Blood Spots for Concentration Assessment in Pharmacokinetic Evaluations</p><p>Tapan K. Majumdar and Danny R. Howard</p><p>5.    Microdosing: Pharmacokinetic and Metabolism Data Early in the Drug Development Process</p><p>Graham Lappin</p><p>6.    Metabolite Testing in Drug Development</p><p>Angus N. R. Nedderman and Don K. Walker</p><p>7.    The –Omics in Drug Development</p><p>Majid Y. Moridani, Robyn P. Araujo, Caroline H. Johnson, and John C. Lindon</p><p>8.    Optimal Design of Pharmacokinetic-Pharmacodynamic Studies</p><p>Lee-Kien Foo and Stephen B. Duffull</p><p>9.    Pharmacokinetic Studies in Pregnant Women</p><p>Jamie L. Renbarger and David M. Haas</p><p>10.  Design, Conduct and Analysis of Thorough QT Studies</p><p>Tanya Russell, Daniel S. Stein, and David J. Kazierad</p><p>11.  Contribution of Quantitative Whole-body Autoradioluminography to the Early Selection and Development of Drug Candidates</p><p>Alain Schweitzer</p><p>12.  Pharmacokinetics, Modeling, and Simulation in the Development of Sunitinib Malate: A Case Study</p><p>Brett E. Houk and Carlo L. Bello</p><p>13.  The Clinical Significance of Drug Transporters in Drug Disposition and Drug Interactions</p><p>Thomas N. Thompson</p>

Rubrieken

    Personen

      Trefwoorden

        Pharmacokinetics in Drug Development